T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 by Annie De Groot | Jun 30, 20202020 TCWP
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation by Sarah Moniz | Aug 15, 2018
Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics by Sarah Moniz | Dec 22, 2017
Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein by Adam | Oct 22, 2016Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein Scios Inc, Brown University, Amgen Clinical Immunology (2007). [ISPRI prediction of immunogenicity]
T-Cell Dependent Immunogenicity of Protein Therapeutics: Preclinical Assessment and Mitigation by Adam | Oct 21, 2016